- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7233
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effects of mutant Ras proteins on the cell signalome ; day:9 ; month:7 ; year:2020 ; pages:1-15
Cancer and metastasis reviews ; (9.7.2020), 1-15
- Creator
-
Takács, Tamás
Kudlik, Gyöngyi
Kurilla, Anita
Szeder, Bálint
Buday, László
Vas, Virag
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10555-020-09912-8
- URN
-
urn:nbn:de:101:1-2020090720424927520533
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takács, Tamás
- Kudlik, Gyöngyi
- Kurilla, Anita
- Szeder, Bálint
- Buday, László
- Vas, Virag
- SpringerLink (Online service)
Other Objects (12)
Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Funktionelle Charakterisierung von RAS-Mutanten im Rhabdomyosarkom
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Entwicklung neuer Inhibitoren für das Ras-Protein und dessen onkogene Mutanten auf Basis von Cyclenderivaten
Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax
The ancestral type of the R-RAS protein has oncogenic potential
Die Interaktionsnetzwerke von Ras-Proteinen
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers
Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Funktionelle Charakterisierung von RAS-Mutanten im Rhabdomyosarkom
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Entwicklung neuer Inhibitoren für das Ras-Protein und dessen onkogene Mutanten auf Basis von Cyclenderivaten
Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax
The ancestral type of the R-RAS protein has oncogenic potential
Die Interaktionsnetzwerke von Ras-Proteinen
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Dependence of NPPS creates a targetable vulnerability in RAS-mutant cancers
Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Funktionelle Charakterisierung von RAS-Mutanten im Rhabdomyosarkom
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Entwicklung neuer Inhibitoren für das Ras-Protein und dessen onkogene Mutanten auf Basis von Cyclenderivaten
Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax
The ancestral type of the R-RAS protein has oncogenic potential
Die Interaktionsnetzwerke von Ras-Proteinen
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers